[Renin-angiotensin system].
Rakugi
Hiromi
H
Department of Geriatric Medicine, Osaka University Graduate School of Medicine.
Ogiwara
Toshio
T
D017667:Adipocytes / Q000378:metabolism; D000577:Amides; D000085962:Angiotensin-Converting Enzyme 2; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D005650:Fumarates; D006973:Hypertension / Q000209:etiology; D007333:Insulin Resistance; D000077405:Irbesartan; D024821:Metabolic Syndrome / Q000209:etiology; D007703:Peptidyl-Dipeptidase A / Q000502:physiology; D011945:Receptors, Angiotensin / Q000502:physiology; D011956:Receptors, Cell Surface / Q000502:physiology; D012084:Renin-Angiotensin System / Q000502:physiology; D013777:Tetrazoles; D025262:Vacuolar Proton-Translocating ATPases / Q000502:physiology; D000093342:Prorenin Receptor
C458319:ATP6AP2 protein, human; D000577:Amides; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D005650:Fumarates; D011945:Receptors, Angiotensin; D011956:Receptors, Cell Surface; D013777:Tetrazoles; C446481:aliskiren; D007703:Peptidyl-Dipeptidase A; C000705307:ACE2 protein, human; D000085962:Angiotensin-Converting Enzyme 2; D025262:Vacuolar Proton-Translocating ATPases; D000077405:Irbesartan; D000093342:Prorenin Receptor